Hapreet Wasan discusses the tumor biology of pancreatic cancer, the potential role of the enzyme asparaginase in treating these cancers, and what advancements he hopes to see in the coming years.
Browsing: Disease Area > Pancreatic
Thomas Seufferlein discusses diagnostic and treatment options for pancreatic cancer, as well as his thoughts on recent advancements, emerging treatments and trials, such as the TRYbeCA1 study.
Although the treatment of metastatic pancreatic adenocarcinoma across Europe generally follows the ESMO guideline, there are substantial geographic variations in treatment patterns used as first-line therapies.
Adjuvant FOLFIRINOX chemotherapy has become the standard of care for pancrearic cancer patients following the release of data from the Phase III PRODIGE 24/CCTG PA.6 trial.
Results of a randomized clinical trial, presented at ASCO 2018, highlight the benefit of preoperative chemoradiotherapy for patients with pancreatic cancer that can be treated with surgery.
The objective of this study is to identify the effect of diabetes mellitus on survival of patients with pancreatic cancer and to determine whether pancreatic cancer and its treatment affect glycemic control.
The use of a new smartphone app could detect early signs of pancreatic cancer, potentially helping to diagnose pancreatic cancer whilst tumors are still treatable.
In this editorial find out about the promises and limitations of gemcitabine monotherapy as an adjuvant chemotherapy in pancreatic adenocarcinoma.
Researchers have identified a panel of biomarkers in serum samples that could accurately detect the early stages of pancreatic cancer.
Listen to our exclusive interview with Philip A Philip to find out about novel agents and strategies on the horizon for pancreatic cancer.